Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [21] Practitioner characteristics and the treatment of children and adolescents with attention deficit hyperactivity disorder
    Mitchell, Philip B.
    Levy, Florence
    Hadzi-Pavlovic, Dusan
    Concannon, Patrick E.
    Hutchins, Paul
    Mulcahy, Desmond L.
    Clarke, Simon D.
    Salmelainen, Pia A.
    Warner, Alexandra
    Hughes, Clifford F.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (06) : 483 - 489
  • [22] Efficacy of atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder
    Dunn, D
    Allen, A
    Thomason, C
    Zhang, S
    Michelson, D
    Kelsey, D
    ANNALS OF NEUROLOGY, 2003, 54 : S143 - S143
  • [23] Clinical guidelines for the treatment of attention deficit hyperactivity disorder in children and adolescents
    Ulloa, RE
    Arroyo, E
    Avila, JM
    Cárdenas, JA
    Cruz, E
    Gómez, D
    Higuera, F
    Rivera, F
    Santos, G
    Velásquez, V
    de la Peña, F
    SALUD MENTAL, 2005, 28 (05) : 1 - 10
  • [24] Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
    Najib, Jadwiga
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 66
  • [25] Diagnosis and treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Brown, MB
    JOURNAL OF COUNSELING AND DEVELOPMENT, 2000, 78 (02): : 195 - 203
  • [26] Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder
    Leggett, Catherine
    Hotham, Elizabeth
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2011, 47 (08) : 512 - 517
  • [27] Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Greenhill, Laurence L.
    McNamara, Nora K.
    Demeter, Christine A.
    Kotler, Lisa A.
    O'Riordan, Mary Ann
    Myers, Carolyn
    Reed, Michael D.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 433 - 445
  • [28] PHARMACOTHERAPEUTIC TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Regnart, J.
    McCartney, J.
    Truter, I
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 148 - 148
  • [29] Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Goldman, LS
    Genel, M
    Bezman, RJ
    Slanetz, PJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (14): : 1100 - 1107
  • [30] Yoga for Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Phan, Thomas Ngoc
    Alam, Safyah
    Wagner, Karen Dineen
    PSYCHIATRIC ANNALS, 2021, 51 (09) : 437 - 442
12345